Product information and disease descriptionPlace of product in therapyApproaches to treatment
Care management intervention strategies
2 evidence topics · 1 source
Risk-stratified follow-up intervals
| Risk category | Quoted interval |
|---|---|
| Intermediate or high risk of disease progression: at least | “every 6 months” |
| Low risk of disease progression: at least | “once a year” |